Ethics approval and consent to participate
The trial has been approved by the Institutional Review Board of Beijing Tiantan Hospital on 16/7/2021 (KY2021-082-02). Written informed consent was obtained from all participants. All methods were carried out in accordance with declaration of Helsinki.